IC 41 and nitazoxanide in patients with hepatitis C

Trial Profile

IC 41 and nitazoxanide in patients with hepatitis C

Phase of Trial: Phase II

Latest Information Update: 08 Nov 2011

At a glance

  • Drugs IC 41; Nitazoxanide; Peginterferon alfa-2a; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Nov 2010 The trial is expected to be initiated in the first half of 2011, according to an Intercell media release.
    • 22 Oct 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top